Russia’s Sputnik V Almost 100% Efficient in Developing Cell Response to COVID-19, Developer Says

Jan 28, 2021 | EARNINGS

MOSCOW (Sputnik) – Russia’s Sputnik V vaccine’s efficiency in formation of cellular immunity to COVID-19 is close to 100 percent, a senior researcher at a genetic engineering laboratory of the Gamaleya institute said on Thursday.

Read More

Pin It on Pinterest